Unimolecular <scp>GLP</scp> ‐1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta‐Cell Survival and Glycaemic Regulation
These studies highlight the clear therapeutic applicability of rationally designed GLP-1/apelin hybrid molecules for the treatment of obesity and T2DM.
Authors
- Nigel Irwin (ORCID: https://orcid.org/0000-0003-4855-964X)
- Sarah Craig (ORCID: https://orcid.org/0000-0002-3123-8834)
- Ananyaa Sridhar (ORCID: https://orcid.org/0000-0002-3865-5067)
- Ethan Palmer (ORCID: https://orcid.org/0000-0002-8936-5844)
- Finbarr P. M. O'Harte
- Elzbieta Krason‐Kidzinska
Institutions
- University of Ulster (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1111/dom.70647
- Primary Topic
- Apelin-related biomedical research
- Type
- article
- Field-Weighted Citation Impact
- 0.00